Quarterly report · Q2

Period2023-07-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥2.8bn2023-07-01 → 2023-12-31Cons.Net sales
Revenue¥8.1bn2022-07-01 → 2023-06-30Cons.Net sales (5-year summary)
Revenue¥4.2bn2022-07-01 → 2022-12-31Cons.Net sales
Operating income−¥455m2023-07-01 → 2023-12-31Cons.Operating income
Operating income¥345m2022-07-01 → 2022-12-31Cons.Operating income
Ordinary income−¥449m2023-07-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥727m2022-07-01 → 2023-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥345m2022-07-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥449m2023-07-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥345m2022-07-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥488m2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥452m2022-07-01 → 2023-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥209m2022-07-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥489m2023-07-01 → 2023-12-31Cons.Profit loss
Net income¥213m2022-07-01 → 2022-12-31Cons.Profit loss
Total assets¥7.1bnat 2023-12-31Cons.Assets
Total assets¥8.2bnat 2023-06-30Cons.Assets
Total assets¥8.0bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥702mat 2023-12-31Cons.Liabilities
Total liabilities¥1.1bnat 2023-06-30Cons.Liabilities
Net assets / equity¥6.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥7.2bnat 2023-06-30Cons.Net assets
Net assets / equity¥6.9bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥4.7bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥5.9bnat 2023-06-30Cons.Cash and deposits
Cash & equivalents¥4.7bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥5.9bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥5.5bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.0bnat 2022-06-30dCons.Cash and cash equivalents
Operating cash flow−¥967m2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥102m2022-07-01 → 2023-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥328m2022-07-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥10m2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow¥160m2022-07-01 → 2023-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥27m2022-07-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥260m2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥130m2022-07-01 → 2023-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥130m2022-07-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-18.652023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1.52023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.272022-07-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82022-07-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.472022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio89.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.6%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio84.4%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 49
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥10m
Reconciling Itemsreconcilingrevenue external2023-07-01 → 2023-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥11m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥156m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥1m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥72m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥270m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2023-07-01 → 2023-12-31¥165m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2023-07-01 → 2023-12-31¥157m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥8m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2023-07-01 → 2023-12-31−¥701,000
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥43m
—segment totalrevenue2023-07-01 → 2023-12-31¥2.9bn
—segment totalrevenue external2023-07-01 → 2023-12-31¥2.8bn
—segment totalrevenue intersegment2023-07-01 → 2023-12-31¥11m
—segment totalsegment profit2023-07-01 → 2023-12-31−¥299m
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-12-31−¥2m
Reconciling Itemsreconcilingrevenue external2022-07-01 → 2022-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-12-31−¥3m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-12-31−¥155m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2022-07-01 → 2022-12-31¥258m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2022-07-01 → 2022-12-31¥258m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2022-07-01 → 2022-12-31¥32m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2022-07-01 → 2022-12-31¥2.0bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2022-07-01 → 2022-12-31¥2.0bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2022-07-01 → 2022-12-31¥398m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2022-07-01 → 2022-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2022-07-01 → 2022-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2022-07-01 → 2022-12-31−¥18m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2022-07-01 → 2022-12-31¥279m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2022-07-01 → 2022-12-31¥277m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2022-07-01 → 2022-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2022-07-01 → 2022-12-31¥43m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2022-07-01 → 2022-12-31¥314m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2022-07-01 → 2022-12-31¥314m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2022-07-01 → 2022-12-31¥45m
—segment totalrevenue2022-07-01 → 2022-12-31¥4.2bn
—segment totalrevenue external2022-07-01 → 2022-12-31¥4.2bn
—segment totalrevenue intersegment2022-07-01 → 2022-12-31¥3m
—segment totalsegment profit2022-07-01 → 2022-12-31¥500m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 441
ItemContextValueUnit
Depreciation and amortization ope cfPrior1YTDDuration9213000JPY
Depreciation and amortization ope cfCurrentYTDDuration12925000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-4180000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-31000JPY
Increase decrease in provision for loss on order received ope cfPrior1YTDDuration-JPY
Increase decrease in provision for loss on order received ope cfCurrentYTDDuration-5072000JPY
Increase decrease in net defined benefit liability ope cfPrior1YTDDuration775000JPY
Increase decrease in net defined benefit liability ope cfCurrentYTDDuration-1515000JPY
Interest income ope cfPrior1YTDDuration-183000JPY
Interest income ope cfCurrentYTDDuration-31000JPY
Compensation income for damage ope cfPrior1YTDDuration-216000JPY
Compensation income for damage ope cfCurrentYTDDuration-3719000JPY
Loss on retirement of noncurrent assets ope cfPrior1YTDDuration61000JPY
Loss on retirement of noncurrent assets ope cfCurrentYTDDuration-JPY
Loss gain on sales of noncurrent assets ope cfPrior1YTDDuration-JPY
Loss gain on sales of noncurrent assets ope cfCurrentYTDDuration134000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration79405000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration-389385000JPY
Decrease increase in inventories ope cfPrior1YTDDuration61017000JPY
Decrease increase in inventories ope cfCurrentYTDDuration203195000JPY
Decrease increase in consumption taxes refund receivable ope cfPrior1YTDDuration-3863000JPY
Decrease increase in consumption taxes refund receivable ope cfCurrentYTDDuration53127000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration-269692000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-279247000JPY
Increase decrease in contract liabilities ope cfPrior1YTDDuration-73825000JPY
Increase decrease in contract liabilities ope cfCurrentYTDDuration-11372000JPY
Increase decrease in accrued consumption taxes ope cfPrior1YTDDuration-94219000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration-11968000JPY
Other net ope cfPrior1YTDDuration-21353000JPY
Other net ope cfCurrentYTDDuration-117929000JPY
Subtotal ope cfPrior1YTDDuration28229000JPY
Subtotal ope cfCurrentYTDDuration-1000315000JPY
Interest income received ope cfPrior1YTDDuration179000JPY
Interest income received ope cfCurrentYTDDuration28000JPY
Compensation for damage received ope cfPrior1YTDDuration216000JPY
Compensation for damage received ope cfCurrentYTDDuration3719000JPY
Income taxes paid refund ope cfPrior1YTDDuration-356523000JPY
Income taxes paid refund ope cfCurrentYTDDuration29790000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration-327897000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration-966777000JPY
Purchase of short term investment securities inv cfPrior1YTDDuration-400000000JPY
Purchase of short term investment securities inv cfCurrentYTDDuration-JPY
Proceeds from redemption of securities inv cfPrior1YTDDuration400000000JPY
Proceeds from redemption of securities inv cfCurrentYTDDuration-JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-21152000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-6851000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-5768000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-3081000JPY
Payments for guarantee deposits inv cfPrior1YTDDuration-102000JPY
Payments for guarantee deposits inv cfCurrentYTDDuration-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-06-30pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-07-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-07-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass